{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T07:12:42Z","timestamp":1789974762927,"version":"4.0.1"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2017,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background and objectives<\/jats:title>\n                    <jats:p>Elevated serum triglyceride\/HDL cholesterol (TG\/HDL-C) ratio has been identified as a risk factor for cardiovascular (CV) disease and mortality in the general population. However, the association of this important clinical index with mortality has not been fully evaluated in patients with ESRD on maintenance hemodialysis (MHD). We hypothesized that the association of serum TG\/HDL-C ratio with all-cause and CV mortality in patients with ESRD on MHD is different from the general population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, setting, participants, &amp; measurements<\/jats:title>\n                    <jats:p>We studied the association of serum TG\/HDL-C ratio with all-cause and CV mortality in a nationally representative cohort of 50,673 patients on incident hemodialysis between January 1, 2007 and December 31, 2011. Association of baseline and time-varying TG\/HDL-C ratios with mortality was assessed using Cox proportional hazard regression models, with adjustment for multiple variables, including statin therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During the median follow-up of 19 months (interquartile range, 11\u201332 months), 12,778 all-cause deaths and 4541 CV deaths occurred, respectively. We found that the 10th decile group (reference: sixth deciles of TG\/HDL-C ratios) had significantly lower risk of all-cause mortality (hazard ratio, 0.91 [95% confidence interval, 0.83 to 0.99] in baseline and 0.86 [95% confidence interval, 0.79 to 0.94] in time-varying models) and CV mortality (hazard ratio, 0.83 [95% confidence interval, 0.72 to 0.96] in baseline and 0.77 [95% confidence interval, 0.66 to 0.90] in time-varying models). These associations remained consistent and significant across various subgroups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Contrary to the general population, elevated TG\/HDL-C ratio was associated with better CV and overall survival in patients on hemodialysis. Our findings provide further support that the nature of CV disease and mortality in patients with ESRD is unique and distinct from other patient populations. Hence, it is vital that future studies focus on identifying risk factors unique to patients on MHD and decipher the underlying mechanisms responsible for poor outcomes in patients with ESRD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2215\/cjn.08730816","type":"journal-article","created":{"date-parts":[[2017,2,13]],"date-time":"2017-02-13T20:10:42Z","timestamp":1487016642000},"page":"591-602","source":"Crossref","is-referenced-by-count":56,"title":["Association of Serum Triglyceride to HDL Cholesterol Ratio with All-Cause and Cardiovascular Mortality in Incident Hemodialysis Patients"],"prefix":"10.2215","volume":"12","author":[{"given":"Tae Ik","family":"Chang","sequence":"first","affiliation":[{"name":"Harold Simmons Center for Kidney Disease Research and Epidemiology, University of California, Irvine School of Medicine, Orange, California;"},{"name":"Department of Internal Medicine, National Health Insurance Service Medical Center, Ilsan Hospital, Goyangshi, Gyeonggi\u2013do, Republic of Korea;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elani","family":"Streja","sequence":"additional","affiliation":[{"name":"Harold Simmons Center for Kidney Disease Research and Epidemiology, University of California, Irvine School of Medicine, Orange, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Soohoo","sequence":"additional","affiliation":[{"name":"Harold Simmons Center for Kidney Disease Research and Epidemiology, University of California, Irvine School of Medicine, Orange, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Woo","family":"Kim","sequence":"additional","affiliation":[{"name":"Harold Simmons Center for Kidney Disease Research and Epidemiology, University of California, Irvine School of Medicine, Orange, California;"},{"name":"Department of Internal Medicine, Soon Chun Hyang University Hospital, Gumi, Republic of Korea;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie M.","family":"Rhee","sequence":"additional","affiliation":[{"name":"Harold Simmons Center for Kidney Disease Research and Epidemiology, University of California, Irvine School of Medicine, Orange, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba P.","family":"Kovesdy","sequence":"additional","affiliation":[{"name":"Division of Nephrology, University of Tennessee Health Science Center, Memphis, Tennessee;"},{"name":"Nephrology Section, Memphis Veterans Affairs Medical Center, Memphis, Tennessee;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moti L.","family":"Kashyap","sequence":"additional","affiliation":[{"name":"Atherosclerosis Research Center, Gerontology Section, Geriatric, Rehabilitation Medicine and Extended Care Health Care Group and"},{"name":"Department of Medicine, University of California, Irvine, Orange, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nosratola D.","family":"Vaziri","sequence":"additional","affiliation":[{"name":"Harold Simmons Center for Kidney Disease Research and Epidemiology, University of California, Irvine School of Medicine, Orange, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamyar","family":"Kalantar-Zadeh","sequence":"additional","affiliation":[{"name":"Harold Simmons Center for Kidney Disease Research and Epidemiology, University of California, Irvine School of Medicine, Orange, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Moradi","sequence":"additional","affiliation":[{"name":"Harold Simmons Center for Kidney Disease Research and Epidemiology, University of California, Irvine School of Medicine, Orange, California;"},{"name":"Nephrology Section, Veterans Affairs Medical Center, Long Beach, California; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2017,2,13]]},"reference":[{"key":"B2-20230813","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.jacc.2008.12.068","article-title":"Obesity and cardiovascular disease: Risk factor, paradox, and impact of weight loss.","volume":"53","author":"Lavie","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"B3-20230813","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.amjmed.2009.06.006","article-title":"The obesity paradox, weight loss, and coronary disease.","volume":"122","author":"Lavie","year":"2009","journal-title":"Am J Med"},{"key":"B4-20230813","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1053\/j.ajkd.2005.05.020","article-title":"Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population.","volume":"46","author":"Kalantar-Zadeh","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"B5-20230813","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1681\/ASN.2006070795","article-title":"Association between serum lipids and survival in hemodialysis patients and impact of race.","volume":"18","author":"Kilpatrick","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"B6-20230813","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000381991","article-title":"Association of serum lipids with outcomes in Hispanic hemodialysis patients of the West versus East Coasts of the United States.","volume":"41","author":"Moradi","year":"2015","journal-title":"Am J Nephrol"},{"key":"B7-20230813","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1046\/j.1523-1755.2002.00324.x","article-title":"Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients.","volume":"61","author":"Iseki","year":"2002","journal-title":"Kidney Int"},{"issue":"Suppl","key":"B8-20230813","doi-asserted-by":"crossref","first-page":"1K","DOI":"10.1016\/j.amjcard.2008.10.002","article-title":"The residual risk reduction initiative: A call to action to reduce residual vascular risk in patients with dyslipidemia.","volume":"102","author":"Fruchart","year":"2008","journal-title":"Am J Cardiol"},{"key":"B9-20230813","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events.","volume":"357","author":"Barter","year":"2007","journal-title":"N Engl J Med"},{"key":"B10-20230813","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1056\/NEJMoa1001282","article-title":"Effects of combination lipid therapy in type 2 diabetes mellitus.","volume":"362","author":"Ginsberg","year":"2010","journal-title":"N Engl J Med"},{"key":"B11-20230813","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.","volume":"365","author":"Boden","year":"2011","journal-title":"N Engl J Med"},{"key":"B12-20230813","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/joim.12036","article-title":"Identifying cardiovascular disease risk and outcome: Use of the plasma triglyceride\/high-density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria.","volume":"273","author":"Salazar","year":"2013","journal-title":"J Intern Med"},{"key":"B13-20230813","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jash.2014.08.002","article-title":"Use of the plasma triglyceride\/high-density lipoprotein cholesterol ratio to identify cardiovascular disease in hypertensive subjects.","volume":"8","author":"Salazar","year":"2014","journal-title":"J Am Soc Hypertens"},{"key":"B14-20230813","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1161\/01.CIR.96.8.2520","article-title":"Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction.","volume":"96","author":"Gaziano","year":"1997","journal-title":"Circulation"},{"key":"B15-20230813","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/archinte.161.3.361","article-title":"Low triglycerides-high high-density lipoprotein cholesterol and risk of ischemic heart disease.","volume":"161","author":"Jeppesen","year":"2001","journal-title":"Arch Intern Med"},{"key":"B16-20230813","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1161\/STROKEAHA.114.006827","article-title":"Nontraditional serum lipid variables and recurrent stroke risk.","volume":"45","author":"Park","year":"2014","journal-title":"Stroke"},{"key":"B17-20230813","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.annepidem.2005.01.005","article-title":"A comparison of lipid variables as predictors of cardiovascular disease in the Asia Pacific region.","volume":"15","author":"Barzi","year":"2005","journal-title":"Ann Epidemiol"},{"key":"B18-20230813","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2310\/JIM.0000000000000044","article-title":"Triglyceride-to-high-density-lipoprotein-cholesterol ratio is an index of heart disease mortality and of incidence of type 2 diabetes mellitus in men.","volume":"62","author":"Vega","year":"2014","journal-title":"J Investig Med"},{"key":"B19-20230813","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ahj.2008.11.014","article-title":"The triglyceride\/high-density lipoprotein cholesterol ratio predicts all-cause mortality in women with suspected myocardial ischemia: A report from the Women\u2019s Ischemia Syndrome Evaluation (WISE).","volume":"157","author":"Bittner","year":"2009","journal-title":"Am Heart J"},{"key":"B20-20230813","doi-asserted-by":"crossref","first-page":"e0123521","DOI":"10.1371\/journal.pone.0123521","article-title":"The association between triglyceride\/high-density lipoprotein cholesterol ratio and all-cause mortality in acute coronary syndrome after coronary revascularization.","volume":"10","author":"Wan","year":"2015","journal-title":"PLoS One"},{"key":"B21-20230813","doi-asserted-by":"crossref","first-page":"e619","DOI":"10.1097\/MD.0000000000000619","article-title":"Triglyceride to high-density lipoprotein cholesterol ratio predicts cardiovascular outcomes in prevalent dialysis patients.","volume":"94","author":"Chen","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"B22-20230813","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.numecd.2015.05.006","article-title":"Higher serum triglyceride to high-density lipoprotein cholesterol ratio was associated with increased cardiovascular mortality in female patients on peritoneal dialysis.","volume":"25","author":"Wu","year":"2015","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B23-20230813","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.298.3.309","article-title":"Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women.","volume":"298","author":"Bansal","year":"2007","journal-title":"JAMA"},{"key":"B24-20230813","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1001\/jama.298.3.299","article-title":"Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women.","volume":"298","author":"Nordestgaard","year":"2007","journal-title":"JAMA"},{"key":"B25-20230813","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1001\/archinte.163.9.1077","article-title":"Relation of triglyceride levels, fasting and nonfasting, to fatal and nonfatal coronary heart disease.","volume":"163","author":"Eberly","year":"2003","journal-title":"Arch Intern Med"},{"key":"B26-20230813","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/01.CIR.60.3.473","article-title":"Atherogenesis: A postprandial phenomenon.","volume":"60","author":"Zilversmit","year":"1979","journal-title":"Circulation"},{"key":"B27-20230813","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/clinchem\/41.1.153","article-title":"Atherogenic nature of triglycerides, postprandial lipidemia, and triglyceride-rich remnant lipoproteins.","volume":"41","author":"Zilversmit","year":"1995","journal-title":"Clin Chem"},{"key":"B28-20230813","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1161\/CIRCRESAHA.115.306249","article-title":"Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: New insights from epidemiology, genetics, and biology.","volume":"118","author":"Nordestgaard","year":"2016","journal-title":"Circ Res"},{"key":"B29-20230813","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/ndt\/gfu022","article-title":"Elevated high-density lipoprotein cholesterol and cardiovascular mortality in maintenance hemodialysis patients.","volume":"29","author":"Moradi","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"B30-20230813","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/ndt\/gfv097","article-title":"Predictors of treatment with dialysis modalities in observational studies for comparative effectiveness research.","volume":"30","author":"Kuttykrishnan","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"B31-20230813","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.amjcard.2004.03.069","article-title":"Accuracy of the triglyceride to high-density lipoprotein cholesterol ratio for prediction of the low-density lipoprotein phenotype B.","volume":"94","author":"Hanak","year":"2004","journal-title":"Am J Cardiol"},{"key":"B32-20230813","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III).","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"B33-20230813","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of competing risk.","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"B34-20230813","doi-asserted-by":"crossref","first-page":"83","DOI":"10.5527\/wjn.v4.i1.83","article-title":"Lipid abnormalities in kidney disease and management strategies.","volume":"4","author":"Pandya","year":"2015","journal-title":"World J Nephrol"},{"key":"B35-20230813","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/sdi.12375","article-title":"Dyslipidemia in dialysis patients.","volume":"28","author":"Qunibi","year":"2015","journal-title":"Semin Dial"},{"key":"B36-20230813","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1681\/ASN.2012080870","article-title":"Association between LDL-C and risk of myocardial infarction in CKD.","volume":"24","author":"Tonelli","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B37-20230813","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/ki.2014.31","article-title":"KDIGO clinical practice guideline for lipid management in CKD: Summary of recommendation statements and clinical approach to the patient.","volume":"85","author":"Wanner","year":"2014","journal-title":"Kidney Int"},{"key":"B38-20230813","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.","volume":"353","author":"Wanner","year":"2005","journal-title":"N Engl J Med"},{"key":"B39-20230813","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.","volume":"360","author":"Fellstr\u00f6m","year":"2009","journal-title":"N Engl J Med"},{"key":"B40-20230813","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): A randomised placebo-controlled trial.","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"key":"B41-20230813","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10157-013-0847-z","article-title":"Role of dyslipidemia in impairment of energy metabolism, oxidative stress, inflammation and cardiovascular disease in chronic kidney disease.","volume":"18","author":"Vaziri","year":"2014","journal-title":"Clin Exp Nephrol"},{"key":"B42-20230813","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1542-4758.2006.01168.x","article-title":"Mechanisms of dyslipidemia of chronic renal failure.","volume":"10","author":"Vaziri","year":"2006","journal-title":"Hemodial Int"},{"key":"B43-20230813","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/ki.2009.177","article-title":"In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide.","volume":"76","author":"Vaziri","year":"2009","journal-title":"Kidney Int"},{"key":"B44-20230813","first-page":"524","article-title":"Salutary effects of hemodialysis on low-density lipoprotein proinflammatory and high-density lipoprotein anti-inflammatory properties in patient with end-stage renal disease.","volume":"103","author":"Vaziri","year":"2011","journal-title":"J Natl Med Assoc"},{"key":"B45-20230813","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.jacc.2012.09.013","article-title":"Dysfunctional high-density lipoprotein in patients on chronic hemodialysis.","volume":"60","author":"Yamamoto","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"B46-20230813","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1681\/ASN.2011070668","article-title":"Serum amyloid A in uremic HDL promotes inflammation.","volume":"23","author":"Weichhart","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"B47-20230813","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrneph.2015.180","article-title":"HDL abnormalities in nephrotic syndrome and chronic kidney disease.","volume":"12","author":"Vaziri","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"B48-20230813","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1053\/j.jrn.2013.01.022","article-title":"Role of HDL dysfunction in end-stage renal disease: A double-edged sword.","volume":"23","author":"Moradi","year":"2013","journal-title":"J Ren Nutr"},{"key":"B49-20230813","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.atherosclerosis.2011.10.038","article-title":"Oxidized high-density lipoprotein as a risk factor for cardiovascular events in prevalent hemodialysis patients.","volume":"220","author":"Honda","year":"2012","journal-title":"Atherosclerosis"},{"key":"B50-20230813","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jamda.2015.07.014","article-title":"Reverse Epidemiology of traditional cardiovascular risk factors in the geriatric population.","volume":"16","author":"Ahmadi","year":"2015","journal-title":"J Am Med Dir Assoc"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201704000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:36:33Z","timestamp":1786368993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201704000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,13]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.08730816","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,13]]}}}